Provided by Tiger Trade Technology Pte. Ltd.

Vaxcyte, Inc.

60.81
+0.07000.12%
Pre-market: 61.130.3180+0.52%04:01 EDT
Volume:1.44M
Turnover:87.94M
Market Cap:9.05B
PE:-7.95
High:62.14
Open:60.29
Low:60.06
Close:60.74
52wk High:65.00
52wk Low:30.81
Shares:148.81M
Float Shares:136.00M
Volume Ratio:1.38
T/O Rate:1.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.6496
EPS(LYR):-5.6333
ROE:-36.51%
ROA:-22.61%
PB:3.28
PE(LYR):-10.79

Loading ...

Vaxcyte to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Aug 28

Vaxcyte Q2 EPS $(1.97) Beats $(2.22) Estimate

Benzinga Earnings
·
Aug 06

Vaxcyte, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Vaxcyte President, CFO Andrew Guggenhime Disposes of 10,000 Common Shares Worth $538,885

Reuters
·
Aug 06

Vaxcyte Q2 FY26 Net Loss Widens to $284.3 Million; R&D Expenses Climb to $267.9 Million

Reuters
·
Aug 06

Vaxcyte Q2 Operating Expenses USD 302.777 Million

Reuters
·
Aug 06

Vaxcyte CEO Grant Pickering Disposes of Common Shares Worth $1.02 Million

Reuters
·
Jul 29

Vaxcyte Files Form 3 Initial Beneficial Ownership Statement for Director John Markels

Reuters
·
Jul 17

Vaxcyte Names John Markels to Board as Heath Lukatch Retires

Reuters
·
Jul 16

Guggenheim Reaffirms Their Buy Rating on Vaxcyte (PCVX)

TIPRANKS
·
Jul 14

Vaxcyte to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Jul 09

Should Early VAX-A1 Trial Progress Require Action From Vaxcyte (PCVX) Investors?

Simply Wall St.
·
Jul 07

Vaxcyte COO Jim Wassil Sells 2,250 Common Shares for $127,708.38

Reuters
·
Jul 07

Vaxcyte CEO Grant Pickering Disposes of USD 1.3 Million in Common Shares

Reuters
·
Jun 27

Analysts Offer Insights on Healthcare Companies: Moderna (MRNA) and Vaxcyte (PCVX)

TIPRANKS
·
Jun 26

Vaxcyte Announces Board Transition and New Director Appointment

TIPRANKS
·
Jun 24

Vaxcyte files initial beneficial ownership statement for director Moncef Slaoui

Reuters
·
Jun 24

Vaxcyte names Moncef Slaoui to board after Jacks Lee retirement

Reuters
·
Jun 24

Mizuho Securities Sticks to Its Buy Rating for Vaxcyte (PCVX)

TIPRANKS
·
Jun 21

Vaxcyte (PCVX) Is Up 8.4% After Starting First-in-Human Trial Of Its Strep A Vaccine

Simply Wall St.
·
Jun 19